Get Topic Updates
Share
Written by the OrganizedWisdom Team with as the reviewer. All original content is supervised by the The OrganizedWisdom Medical Review Team
washingtonpost.com
1 of 0
Resource Description:
Rockville-based Human Genome Sciences announced Monday that its experimental lupus drug has completed its final round of testing at a higher dose and will be headed to the Food and Drug Administration for approval.
« Back to the New Lupus Drug Shows Promise WisdomCard
Related Health Centers: